Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 Cells in Subjects with Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.